FAST NEWS: Legend Biotech Plans $250 Million ADS Public Offering
The latest: Genscript Biotech Corp. (1548.HK) announced its New York-listed subsidiary, Legend Biotech Corp. (LEGN.US), plans to conduct a public offering of $250 million worth of American Depository Shares (ADS).…
Recent Articles
RELATED ARTICLES
-
GenScript losses shrink on strong growth for cancer cell therapy
1548.HK
-
FAST NEWS: Hillhouse invests $22 million in Legend Biotech
LEGN.US
-
Legend Holdings shows diversification isn’t always a winning formula
3396.HK
-
FAST NEWS: Legend Biotech to raise $300 million from share sale
LEGN.US 1548.HK
-
FAST NEWS: Legend Biotech shares jump on rising cancer drug sales
LEGN.US
-
FAST NEWS: Legend Biotech’s revenue soars, but fails to turnaround losses
LEGN.US
Discover hidden China stock gems in our weekly newsletter